BASAGLAR—the only insulin glargine with the lowest branded co-pay on both CVS/caremark™ and Express Scripts® 2017 national commercial formularies, effective January 1, 2017

Now available at 2nd-lowest branded co-pay on UnitedHealthcare® commercial formularies, and the only basal insulin with a generic tier co-pay starting April 1, 2017

  • Source: Data on File, Lilly USA, LLC BAS20161005A as of October 5, 2016, and is subject to change without notice by a health plan or state. Please contact the plan or state for the most current information
  • This information is not a guarantee of coverage or payment (partial or full). Actual benefits are determined by each plan administrator in accordance with its respective policy and procedures
  • The formulary information does not include generic medications in this therapeutic class
  • This list may not be an exhaustive list of all plans in your area and the coverage of other plans in your area may vary
  • Employers and employer groups may also offer additional benefit designs, which may be different than described
  • The company/plan names listed do not imply their endorsement of Boehringer Ingelheim Pharmaceuticals, Inc, Lilly USA, LLC, or the product(s) referenced
  • Boehringer Ingelheim Pharmaceuticals, Inc and Lilly USA, LLC do not endorse any particular plan. Other product and company names mentioned herein are the trademarks of their respective owners
  • The formulary information in this document is for select products that share an approved indication with BASAGLAR. Inclusion of products in this statement does not establish clinical comparability of the products for any and all indications and should not be seen as making a claim regarding safety or efficacy

BASAGLAR Savings Card

Your eligible patients can save on their prescription of BASAGLAR. Please see Savings Card for eligibility requirements, and specific terms and conditions.

Each card has a unique ID number.

Please do not make copies.


Invalid email address.